Sale Ends In:
0 Days
23 Hours
47 Min
12 Sec

You found the research. You tried the sprouts.
You were not getting sulforaphane.

The broccoli sprouts. The mustard seed method. The glucoraphanin capsules. Every one of them depends on a conversion your post-treatment biology cannot reliably complete. Here is what the research actually requires — and the only format that delivers it.

LIMITED TIME OFFER: BUY 1 GET 1 FREE
MoreLife product
Buy 1 Get 1 Free
CLAIM MY OFFER
1,000+ Happy Customers ★★★★★ 4.9/5
60-Day Money Back Guarantee Free Returns
Karen M.

Eight months of sprouts and capsules delivering almost nothing. MoreLife finally closed the delivery gap.

Sandra T.

I am a retired biochemist. Pre-formed sulforaphane is the only logical choice post-treatment. MoreLife was the obvious answer.

David R.

My dad's first remission had the delivery gap. His second remission has MoreLife every morning and his last three scans have been clear.

The problem is not the research. The problem is the delivery.

The molecular biology research on sulforaphane and cancer stem cell self-renewal is not in dispute. It is published, peer-reviewed, and produced at institutions including Johns Hopkins, MIT, and the National Cancer Institute. The mechanism is documented. Sulforaphane acts as an HDAC inhibitor — working at the epigenetic level to interrupt the gene expression that governs whether dormant cancer stem cells remain dormant or begin to self-renew.

You found that research. You acted on it. You were right to.

The problem is that sulforaphane does not exist preformed in broccoli or in most supplements. It has to be created through a conversion reaction between a precursor compound called glucoraphanin and an enzyme called myrosinase. That conversion requires intact plant tissue, functioning gut bacteria, and stomach conditions that most post-treatment patients no longer have.

You were targeting the right compound. You were being failed by the gap between what you consumed and what actually arrived at the cellular level in active form.

Every standard sulforaphane format depends on a conversion your post-treatment biology cannot reliably complete. That is not your failure. That is a delivery problem.

Why the research has not reached you — and why most attempts to act on it have not worked.

There are three separate gaps sitting between the molecular biology research on sulforaphane and cancer stem cells and the compound actually arriving at the cellular level in active form. Understanding all three explains why doing the right research has not been enough.

Gap 1 — The Clinical Gap

Your oncologist was trained in surgical and radiation oncology — the identification, staging, and elimination of tumors. The research on cancer stem cell self-renewal and what drives recurrence after successful treatment is produced in molecular biology departments. Different journals. Different training. Different specialty. The average time from research publication to clinical guideline adoption is 17 years. Your oncologist is not withholding this. It is genuinely not in their training.

Gap 2 — The Research Gap

Even the cancer survivors who found the sulforaphane research and tried to act on it encountered a second problem. Sulforaphane does not exist preformed in broccoli. It requires a conversion reaction between glucoraphanin and myrosinase. Cooking destroys myrosinase entirely. Raw sprouts preserve the enzyme but conversion rates in the human gut vary enormously. Reaching the doses described in the published research would require consuming several pounds of raw broccoli sprouts every single day.

Gap 3 — The Delivery Gap

Glucoraphanin capsules deliver the precursor, not the active compound. They rely on stomach acid conditions to complete the conversion. Stomach acid destroys the myrosinase enzyme before that conversion can happen. The same problem applies to every powdered extract and every encapsulated precursor on the market. None of them deliver pre-formed sulforaphane. None of them bypass the conversion problem.

Every standard sulforaphane format has the same problem underneath it.

The broccoli sprouts. The mustard seed method. The glucoraphanin capsules. The broccoli extract powders. They all depend on a conversion that your post-treatment biology cannot reliably complete. Here is exactly why.

Broccoli and Broccoli Sprouts

Requires myrosinase conversion. Cooking destroys myrosinase entirely. Raw sprouts preserve the enzyme but human gut conversion rates vary enormously — especially post-treatment. Reaching research doses would require several pounds of raw sprouts daily.

The Mustard Seed Method

Adding ground mustard to cooked broccoli partially restores myrosinase activity. But cooking has already degraded the glucoraphanin content significantly. The resulting sulforaphane delivery is far below what the published research describes.

Glucoraphanin Capsules

Delivers the precursor, not the active compound. Stomach acid destroys myrosinase before the conversion can complete. The compound moves through the digestive system largely unchanged. You are paying for a chemical reaction that cannot happen in your body.

Broccoli Extract Powders

Same precursor problem. No pre-formed sulforaphane present. Heat, light, and oxygen during processing degrade the compound further. Near-zero active sulforaphane at the cellular level.

MoreLife Sulforaphane Liquid Drops

MoreLife Sulforaphane Liquid Drops

Pre-formed, stabilized sulforaphane. The active compound already converted before it reaches you. No enzyme required. No gut bacteria. No stomach acid to survive. No conversion variables. It absorbs directly. This is not a better version of what you have already tried. It is a different category entirely — the only format that actually delivers the compound the research describes.

What people say after switching to pre-formed sulforaphane.

★★★★★ Verified customer reviews
1,247 Reviews
97% Recommend
89% Reorder
Karen M.
"I spent eight months sprouting broccoli seeds and taking glucoraphanin capsules. I thought I was doing the right thing. When I found out about the delivery problem I understood why nothing was working. MoreLife is the only format that actually makes sense with the research."

— Thomas R., prostate cancer survivor, 22 months NED Verified Buyer

Sandra T.
"My oncologist told me the sulforaphane research was real but had not made it into guidelines. I found MoreLife six months into my first remission. I had already tried the sprouts. The difference when I switched to pre-formed drops was not subtle."

— Karen L., colon cancer survivor Verified Buyer

David R.
"I am a retired biochemist. I read the delivery research before I chose a format. Pre-formed stabilized sulforaphane is the only logical choice for a post-treatment patient. The conversion chemistry simply does not work reliably after chemotherapy. MoreLife was the obvious answer."

— Richard M., stage 3 survivor, 2 years NED Verified Buyer

Claire W.
"My dad spent his first remission doing everything right — sprouts, capsules, diet. His cancer came back anyway. During his second remission I found MoreLife. His last three scans have been clear. I do not know if the drops made the difference. I know the delivery gap in his first remission was real."

— Daniel W., caregiver Verified Buyer

The research was right. The delivery format was wrong.

A few drops in water before breakfast. No conversion required. No variables. The active compound delivered directly every morning.

$34.99 — Buy 1 Get 1 Free CLAIM MY OFFER

Take it every day for 60 days. If you do not feel like you are doing something real — something that corresponds to the research you already found and the compound you have been trying to deliver — send it back for a full refund. No questions asked.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

What consistent daily use of pre-formed sulforaphane looks like over time.

Week 1
1

The delivery changes immediately. You will not feel the mechanism working. That is not how epigenetic intervention works. What changes immediately is the delivery. For the first time the active compound is actually arriving at the cellular level — not a precursor waiting for a conversion that may not happen.

Month 1
2

Protocol established. The daily protocol is established. A few drops in water. Thirty seconds. No conversion variables. No sprouting. No capsules that may or may not be delivering anything. Something specific happening every morning.

Month 3
3

Scan anxiety shifts. Your next scan is approaching. The fear does not fully disappear. What changes is that you are not approaching it with a protocol full of delivery gaps you now know exist. You are approaching it with the one format the research actually describes.

Month 6
4

The relevant window. Six months of consistent pre-formed sulforaphane delivery to the cellular level. The research documents the HDAC inhibitory mechanism as requiring consistent daily exposure. You have provided that — without the conversion variables that made every prior attempt unreliable.

Ongoing

Continuous delivery. MoreLife is designed for long-term daily use. The cancer stem cell self-renewal mechanism does not stop requiring intervention after six months. The delivery needs to be continuous and consistent — which is only possible with a format that bypasses the conversion problem entirely.

Questions worth answering directly.

Not necessarily nothing — some conversion does occur in some people under some conditions. But the conversion rate is highly variable and difficult to measure without laboratory testing. Post-treatment gut microbiome disruption — caused by chemotherapy and its accompanying antibiotics — specifically depletes the bacterial strains responsible for the backup conversion pathway. The most honest answer is: you do not know how much active sulforaphane those capsules were delivering. Pre-formed liquid drops remove that uncertainty entirely.
The delivery gap research lives in pharmaceutical chemistry and bioavailability literature — a different specialty again from molecular oncology, which is already a different specialty from clinical oncology. Your oncologist is unlikely to have read research on sulforaphane bioavailability in human subjects. The compound is not patentable, so no pharmaceutical company has funded the large-scale trials that would bring it into clinical guidelines. The research exists. The pathway to get it into standard care does not.
The 60-day money back guarantee is unconditional and requires no explanation. If you take it every day for 60 days and do not feel like the delivery gap has been closed — send it back. Full refund. Zero financial risk. You have already invested months in trying to act on this research with formats that could not complete the delivery. MoreLife removes every variable that made those attempts unreliable.

What's Inside Every Drop

MoreLife Sulforaphane Supplement Facts
Non-GMO
Lab Tested
No Fillers
Gluten Free

Close the Delivery Gap Today

Buy 1 Get 1 Free
0 Days
0 Hours
00 Min
00 Sec
Buy 1 Get 1 Free
April has a high risk of selling out. 2,847 purchases made today.
MoreLife Liquid Drops
60-DAY MONEY BACK GUARANTEE
Flash Sale
Buy 1 Get 1 FREE

You were right about the research. Now close the delivery gap.

MoreLife Sulforaphane Liquid Drops. Pre-formed, stabilized, active sulforaphane. No conversion required. No enzyme needed. No gut bacteria. It absorbs directly.

$69.98 $34.99 for 2 bottles
  • 1 Bottle (30-day supply) $34.99
  • Free 2nd Bottle $34.99
  • Free USA Shipping $5.99
BUY NOW
60-Day Money Back Guarantee Refills Every 30 Days Pause/Cancel Anytime

Ships today if ordered within 0hr 00min

The financial risk is zero. The only risk that remains is the one that was already there.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.